BiotechTube
Home/Glycadia Pharmaceuticals/Clyde Shearman, PhD
CS

Clyde Shearman, PhD

President & Chief Scientific Officer

Glycadia Pharmaceuticals

Therapeutic Areas

DiabetesNephrologyOphthalmologyCardiovascular

Glycadia Pharmaceuticals Pipeline

DrugIndicationPhase
GLY-230Diabetic complications (Nephropathy focus)Phase 2
GLY-220Diabetic macrovascular diseasePre-clinical
ES12 mAbDiabetic macrovascular diseasePre-clinical
A717 mAbDiabetic microvascular diseasePre-clinical

Leadership Team at Glycadia Pharmaceuticals

PM
Patrick M. O’Keefe
Chief Executive Officer
SS
Sarabjit S. Ashta
Chief Business Officer
JB
John Brennan, PhD
Chief Development Officer
View full Glycadia Pharmaceuticals profile